back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-07 17:30 Tx date 2025-01-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-250,000 vol |
250,000 | |
| Filed 2025-04-07 17:25 Tx date 2025-01-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
492,415 | |
| Filed 2024-12-19 16:21 Tx date 2024-12-12 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,599
+10,704 vol $0.71 each |
242,415 | |
| Filed 2024-12-02 13:10 Tx date 2024-11-28 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+15,000 vol $0.75 each |
231,711 | |
| Filed 2024-11-26 14:45 Tx date 2024-11-22 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+250,000 vol |
500,000 | |
| Filed 2024-07-27 15:32 Tx date 2024-07-26 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,349
+3,916 vol $0.60 each |
216,711 | |
| Filed 2024-05-07 22:54 Tx date 2024-05-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,280
+3,000 vol $0.76 each |
212,795 | |
| Filed 2023-12-10 19:53 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+22,700 vol $1.10 each |
209,795 | |
| Filed 2023-12-10 19:50 Tx date 2023-12-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2023-12-10 19:48 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-10 19:44 Tx date 2023-12-06 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+250,000 vol $1.20 each |
2,850,000 | |
| Filed 2023-12-10 19:40 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,250,000
+1,250,000 vol $1.80 each |
2,600,000 | |
| Filed 2023-12-10 19:39 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+750,000 vol $1.00 each |
1,350,000 | |
| Filed 2023-12-10 19:39 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+250,000 vol $1.80 each |
600,000 | |
| Filed 2023-12-10 19:38 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2023-12-10 19:38 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+22,700 vol $1.10 each |
||
| Filed 2023-12-10 19:37 Tx date 2022-05-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,200
+22,000 vol $1.10 each |
187,095 | |
| Filed 2023-12-10 19:37 Tx date 2022-05-04 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+15,000 vol $1.10 each |
165,095 | |
| Filed 2023-12-10 19:36 Tx date 2022-02-10 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,875
+4,700 vol $1.25 each |
150,095 | |
| Filed 2023-12-10 19:36 Tx date 2022-01-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,280
+25,600 vol $1.30 each |
145,395 | |
| Filed 2023-12-10 19:35 Tx date 2021-08-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,405
+5,700 vol $1.65 each |
119,795 | |
| Filed 2023-12-10 19:35 Tx date 2021-08-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,220
+6,800 vol $1.65 each |
114,095 | |
| Filed 2023-12-10 19:34 Tx date 2021-05-14 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,000
+35,000 vol $1.40 each |
107,295 | |
| Filed 2023-12-10 19:34 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
72,295 | ||
| Filed 2022-12-01 23:52 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+227,000 vol $0.11 each |
||
| Filed 2022-09-30 16:11 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,250,000
+12,500,000 vol $0.18 each |
||
| Filed 2022-09-30 16:04 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+7,500,000 vol $0.10 each |
||
| Filed 2022-05-25 14:22 Tx date 2022-05-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,200
+220,000 vol $0.11 each |
||
| Filed 2022-05-06 23:23 Tx date 2022-05-04 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+150,000 vol $0.11 each |
||
| Filed 2022-02-10 16:34 Tx date 2022-02-10 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,875
+47,000 vol $0.125 each |
||
| Filed 2022-01-27 14:49 Tx date 2022-01-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,280
+256,000 vol $0.13 each |
||
| Filed 2021-12-10 14:15 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+2,500,000 vol $0.18 each |
||
| Filed 2021-08-27 13:04 Tx date 2021-08-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,405
+57,000 vol $0.165 each |
||
| Filed 2021-08-27 13:03 Tx date 2021-08-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,220
+68,000 vol $0.165 each |
||
| Filed 2021-05-17 15:39 Tx date 2021-05-14 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,000
+350,000 vol $0.14 each |
||
| Filed 2020-11-10 23:15 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-10 22:46 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-01 23:52 Tx date 2022-11-30 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,970
+227,000 vol $0.11 each |
2,097,950 | |
| Filed 2022-09-30 16:11 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,250,000
+12,500,000 vol $0.18 each |
26,000,000 | |
| Filed 2022-09-30 16:04 Tx date 2022-09-29 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+7,500,000 vol $0.10 each |
13,500,000 | |
| Filed 2022-05-25 14:22 Tx date 2022-05-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,200
+220,000 vol $0.11 each |
1,870,950 | |
| Filed 2022-05-06 23:23 Tx date 2022-05-04 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+150,000 vol $0.11 each |
1,650,950 | |
| Filed 2022-02-10 16:34 Tx date 2022-02-10 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,875
+47,000 vol $0.125 each |
1,500,950 | |
| Filed 2022-01-27 14:49 Tx date 2022-01-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,280
+256,000 vol $0.13 each |
1,453,950 | |
| Filed 2021-12-10 14:15 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+2,500,000 vol $0.18 each |
6,000,000 | |
| Filed 2021-08-27 13:04 Tx date 2021-08-27 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,405
+57,000 vol $0.165 each |
1,197,950 | |
| Filed 2021-08-27 13:03 Tx date 2021-08-24 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,220
+68,000 vol $0.165 each |
1,140,950 | |
| Filed 2021-05-17 15:39 Tx date 2021-05-14 |
$LOVE
Cannara Biotech Inc. |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,000
+350,000 vol $0.14 each |
1,072,950 | |
| Filed 2020-11-10 23:15 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,500,000 | ||
| Filed 2020-11-10 22:46 Tx date 2020-11-10 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Sosiak, Nicholas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
722,950 |